Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings

Accept

;

Corporate profile

Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We’re driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs. We are focussing all of our activities and efforts on moving towards our vision of a world free of pain.

Corporate Videos


“Although few people die of pain, many still die in pain, while even more live in pain. We will leave no stone unturned to help these patients.”

Gabriel Baertschi

Chief Executive Officer, Grünenthal

As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to people living with pain worldwide. Strong ongoing partnerships with leading healthcare and development organisations bring our new products to life. We’re a fully integrated pharmaceutical company that offers support along the entire value chain – from drug development through to commercialisation.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 29 countries across Europe, Latin America and the US. Our products are sold in more than 100 countries. In 2019, Grünenthal employed around 4,700 people and achieved sales of € 1.4 billion.

Strong and capable team
4,700

employees worldwide

Solid revenue base
1.4

billion euro in 2019

Commercial presence in
29

countries across Europe, Latin America and the US

Products sold in over
100

countries

International network
2

Research Unit Aachen, Innovation Hub Boston

Production capacities
5

manufacturing sites in Europe and Latin America

Our unique commit­ment 
Pain is a huge burden. It impacts patients – as well as their families, friends, caregivers and society as a whole. As a global leader in pain management for nearly 50 years, we’re driven to seek new solutions to relieve pain.

Social Responsi­bility
Caring for the world around us is a big part of who we are – from a patient’s pain to climate change – we’re committed to doing what we can to tackle these issues, big and small.
 

Global Capabilities
Although firmly rooted in Germany, today we’re very much a growing global business: since spreading our wings beyond Germany in the 1960’s, we have continued to grow steadily.
 
 

Pipeline
In our quest to improve the lives of even more patients in need we enrich our expertise in pain management with a complementary diversification into devices and technologies.